Amish C. Shah, M.D., Ph.D.

faculty photo
Assistant Professor of Clinical Pediatrics
Department: Pediatrics

Contact information
Center for Childhood Cancer Research and Division of Oncology
The Children’s Hospital of Philadelphia
Colket Translational Research Building - 3rd Floor
3501 Civic Center Blvd
Philadelphia, PA 19104
Office: 267-426-7598
Fax: 215-590-9956
Education:
BS (Biochemistry & Molecular Biology, Summa Cum Laude)
University of Georgia, 1999.
Ph.D. (Medical Scientist Training Program )
University of Alabama School of Medicine, 2006.
M.D. (Medical Scientist Training Program )
University of Alabama School of Medicine, 2008.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Selected Publications

Mahdi J, Shah AC, Sato A, Morris SM, McKinstry RC, Listernick R, Packer RJ, Fisher MJ, Gutmann DH: A multi-institutional study of brainstem gliomas in children with neurofibromatosis type 1. Neurology 88(16): 1584-1589, April 2017.

Shah Amish C, Minturn Jane E, Li Yimei, Belasco Jean B, Phillips Peter C, Kang Tammy I, Cole Kristina A, Waanders Angela J, Pollack Rosanna, Didomenico Concetta, Wildes Cynthia, Fisher Michael J: Carboplatin Rechallenge After Hypersensitivity Reactions in Pediatric Patients With Low-Grade Glioma. Pediatric blood & cancer 63(1): 21-6, Jan 2016.

Shah AC, Kelly DR, Nabors LB, Oakes WJ, Hilliard LM, Reddy AT.: Treatment of primary CNS lymphoma with high-dose methotrexate in immunocompetent pediatric patients. Pediatr Blood Cancer 55(6): 1227-30, Dec 2010.

Shah AC, Parker JN,Shimamura M, Cassady KA.: Spontaneous and engineered compensatory HSV mutants that counteract the host antiviral PKR response. Viruses 2(3): 510-522, 2009.

Shah AC, Parker JN, Gillespie GY, Lakeman FD, Meleth S, Markert JM, Cassady KA.: Enhanced antiglioma activity of chimeric HCMV/HSV-1 oncolytic viruses. Gene Therapy 14(13): 1045-54, 2007.

Shah AC, Price KH, Parker JN, Samuel SL, Meleth S, Cassady KA, Gillespie GY, Whitley RJ, Markert JM.: Serial passage through human glioma xenografts selects for 134.5 HSV-1 mutant that exhibits decreased neurotoxicity & prolongs survival of mice with experimental brain tumors. J of Virology 80(15): 7308-15, 2006.

Shah AC and Markert JM.: Viral therapy for the treatment of malignant gliomas. Glioblastoma Multiforme. Markert JM, DeVita VT, Rosenberg SA, Hellman S. (eds.). Jones and Bartlett Publishers, Page: 226, 2004 Notes: ISBN-13: 978-0763726409, ISBN-10: 0763726400.

Shah AC, Benos D, Gillespie GY, Markert JM.: Oncolytic viruses: clinical applications as vectors for the treatment of malignant gliomas. J of Neurooncology 65(3): 203-26, 2003.

Shah AC, Parker JN, Gillespie GY, Whitley RJ, Markert JM.: In vivo serial passaging of recombinant HSV-1 in human glioma flank tumors to select mutants with enhanced anti-tumor activity. Neuro-oncology 4:326-7, Abst72, 2002. Neuro-oncology 4: 326-7, 2002.

back to top
Last updated: 07/11/2017
The Trustees of the University of Pennsylvania